IM-862
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for IM-862, covering 2013-11-06 to 2014-05-22. Get the full timeline:
Most recent: Clinical Trial Update: IM-862 in Treating Patients With Recurrent Ovarian Cancer [Phase 1]